• LAST PRICE
    0.6600
  • TODAY'S CHANGE (%)
    Trending Down-0.0189 (-2.7839%)
  • Bid / Lots
    0.6200/ 4
  • Ask / Lots
    0.7159/ 1
  • Open / Previous Close
    0.7100 / 0.6789
  • Day Range
    Low 0.6495
    High 0.7158
  • 52 Week Range
    Low 0.4900
    High 1.5950
  • Volume
    302,512
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.6789
TimeVolumeALZN
09:32 ET575710.7158
09:35 ET1000.715699
09:39 ET31310.69
09:42 ET9350.709999
09:44 ET15000.71
09:46 ET26000.69
09:48 ET121100.7143
09:53 ET11000.70225
09:55 ET13000.7143
09:57 ET52000.71
10:00 ET20000.714
10:02 ET1000.7116
10:04 ET2000.7139
10:08 ET27970.712
10:09 ET254930.71
10:11 ET31000.7048
10:13 ET7000.713999
10:15 ET25700.7119
10:18 ET10650.71205
10:22 ET1120.71205
10:24 ET3000.707125
10:33 ET6000.70735
10:36 ET124150.7048
10:38 ET2600.7099
10:42 ET3000.7099
10:44 ET12320.7048
10:45 ET4000.704
10:47 ET11000.7
10:58 ET99910.69
11:00 ET2000.694949
11:02 ET10000.69
11:05 ET16000.69
11:07 ET1000.694899
11:09 ET7500.692449
11:12 ET7000.692
11:14 ET20000.6901
11:16 ET1500.694899
11:20 ET19000.6913
11:23 ET6000.691
11:30 ET2000.69
11:32 ET56000.69
11:38 ET3000.6875
11:41 ET2000.69105
11:48 ET125180.68
11:50 ET1000.6801
12:06 ET3000.6921
12:28 ET61000.6802
12:37 ET19000.6819
12:46 ET7200.6946
12:55 ET1220.688249
01:08 ET2000.688
01:09 ET2930.6909
01:11 ET11000.6874
01:18 ET1000.6907
01:33 ET6000.690901
01:40 ET59380.685
01:45 ET1000.6839
02:07 ET23000.6802
02:09 ET81070.67
02:12 ET107260.6569
02:14 ET53670.6543
02:16 ET121650.6544
02:18 ET7880.6547
02:20 ET7890.675
02:23 ET4000.68
02:27 ET1000.6747
02:32 ET24000.67
02:34 ET4000.67
02:36 ET3000.6545
02:38 ET5000.6545
02:41 ET1000.669899
02:45 ET1000.6698
02:48 ET18080.68
02:50 ET17780.6702
02:52 ET89520.68769
02:54 ET2000.6789
03:10 ET1000.6875
03:17 ET50000.6799
03:26 ET105500.6749
03:28 ET1000.6701
03:30 ET1000.67495
03:33 ET1000.6701
03:35 ET3000.6749
03:37 ET3000.6701
03:39 ET1260.67
03:42 ET3000.6748
03:44 ET22250.67
03:46 ET95040.655
03:51 ET2200.669799
03:53 ET10000.6698
03:55 ET38000.66
03:57 ET9500.66
04:00 ET15830.66
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALZN
Alzamend Neuro Inc
63.6M
-4.9x
---
United StatesIMNM
Immunome Inc
63.9M
-1.7x
---
United StatesHEPA
Hepion Pharmaceuticals Inc
64.0M
-1.4x
---
United StatesMYMD
MyMD Pharmaceuticals Inc
64.3M
-4.3x
---
United StatesGNPX
Genprex Inc
64.4M
-2.8x
---
United StatesAURX
Nuo Therapeutics Inc
64.8M
-18.4x
---
As of 2023-01-29

Company Information

Alzamend Neuro, Inc. is an early clinical-stage biopharmaceutical company. The Company is focused on developing products for the treatment of Alzheimer’s disease (Alzheimer’s), bipolar disorder, major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two therapeutic drug candidates: AL001 and AL002. The AL001 is a cocrystal technology delivering a therapeutic combination of lithium, proline and salicylate, known as AL001, through two royalty-bearing worldwide licenses from the University of South Florida Research Foundation, Inc. (licensor). The Company’s AL002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s, known as AL002 or CA022W, through a royalty-bearing worldwide license from the licensor.

Contact Information

Headquarters
3500 Lenox Rd. NE, Suite 1500ATLANTA, GA, United States 30326
Phone
302-636-5400
Fax
302-636-5454

Executives

Chairman of the Board
William Horne
Chief Executive Officer, Director
Stephan Jackman
Chief Financial Officer
David Katzoff
Executive Vice President, General Counsel, Director
Henry Nisser
Senior Vice President - Finance
Kenneth Cragun

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$63.6M
Revenue (TTM)
$0.00
Shares Outstanding
96.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.13
Book Value
$0.14
P/E Ratio
-4.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.